A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.
Document Type
Journal Article
Publication Date
7-2-2019
Journal
Molecular cancer research : MCR
DOI
10.1158/1541-7786.MCR-19-0415
APA Citation
Olender, J., Wang, B., Ching, T., Garmire, L., Garofano, K., Ji, Y., Knox, T., Latham, P., Nguyen, K., Rhim, J., & Lee, N. (2019). A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance.. Molecular cancer research : MCR, (). http://dx.doi.org/10.1158/1541-7786.MCR-19-0415
Peer Reviewed
1